Discover the latest developments towards achieving safe and effective NK cell-based therapy for a variety of cancer types
Cell Therapy Analytics Online Symposium 2023
Published on :Cell Therapy Analytics Online Symposium 2023 encompasses novel characterisation techniques & robust analytical tools to ensure safe, quality therapeutic cell products are advanced through to the clinic.
Python for Research Scientists

Python is a popular scripting language that is used by data professionals because of its many-popular statistical libraries. The live remote three-day lecture and hands-on computer-based laboratory workshop is designed [….]
EV Analytics: Know your Process & Define your Product



Size, heterogeneity, complex composition, and varying manufacturing processes make exosomes or extracellular vesicles a challenge for conventional analytical tools and strategies. Without thorough characterization from start to finish, you’ll be [….]
Kite Launches Program to Attract and Hire Veterans



Kite’s cell manufacturing facility in Frederick has recently launched what it calls its Veteran Pathways Program. The program is led by veteran hiring program strategist Bre Cameron. Cameron is a Navy veteran with more than a decade of experience in talent acquisition.
Translational Potential of hMSCs for Ocular Diseases



Join RoosterBio on Tuesday, August 23rd at 1:00 PM EST for our latest webinar: Translational Potential of hMSCs for Ocular Diseases. This seminar will be presented by Dr. Ali Djalilian, [….]
Miltenyi Biotec promotes Markus Weiss to Executive Vice President



Markus Weiss, who in this role is responsible for supporting the North American Business Units and Divisions has 18 years of experience in operationalizing strategy, preserving and growing value, scaling culture as well as business transformations. He is experienced in divisional, regional and country level leadership roles in technology, life science, manufacturing, construction and financial services.
5 Top Maryland Cell and Gene Therapy Companies Actively Searching for Talent



The BHCR cluster, in particular, includes a host of emerging and established cell and gene therapy companies, as well one of the deepest and most advanced biomanufacturing infrastructures in the U.S. While the cell and gene therapy industry still faces challenges like high manufacturing costs, high cost per dose to patients and complex supply chain issues, this sector remains very healthy and is continuing to grow rapidly in our region and globally.
CRB Life Sciences Report Highlights Looming Changes in Cell Therapy Space



The Horizon report is based on survey responses from more than 500 industry leaders who provide insight into all corners of the industry. The investigation of cell and gene therapies is proving to be a disruptive space that is reshaping biopharma business models. When cell therapies first went into human testing, Walters said the big question on the minds of the scientists was, “will it work?”
Cartesian Therapeutics to double footprint, headcount in Gaithersburg



Gaithersburg’s Cartesian Therapeutics Inc. is expanding its local footprint and initiating an aggressive hiring spree as the company bolsters its leadership team — and looks to get a cell therapy candidate through the clinic.
The biopharma, which already occupies about 4,500 square feet at 704 Quince Orchard Road, is taking over another 3,500 square feet adjacent to its existing space in the building, Dr. Murat Kalayoglu, president and CEO of Cartesian, told the Washington Business Journal.
The company declined to disclose the projected cost of the expansion, citing confidentiality reasons per its contract with Alexandria Real Estate Equities Inc. (NYSE: ARE), which in partnership with South Duvall — an affiliate of Rockville’s Scheer Partners — paid $6.9 million for the 80,000-square-foot office building in 2018. The building in the Gaithersburg biotech corridor is also home to a flurry of local players, including Novavax Inc. (NASDAQ: NVAX), miRecule Inc., VLP Therapeutics Inc. and others.